GlassScriptPhysician profile
Peter Anthony Rosa
NPI 1861675233
$2,885.52
in general payments reported to CMS, 2019-2025
6 companies · $201 in 2025
The $201 reported for 2025 was more than what a typical Oral and Maxillofacial Surgery provider received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,389 · 2020: $21.45 · 2021: $163 · 2022: $111 · 2025: $201.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $201.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $201.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $2,603.85 | 2019-2025 | |
| Optinose US, INC. | $162.07 | 2021-2022 | |
| Biohorizons Implant Systems INC. | $40.88 | 2021 | |
| Genzyme Corporation | $40.13 | 2021 | |
| Ace Surgical Supply Co., INC. | $20.72 | 2019 | |
| Alk-Abello, INC | $17.87 | 2022 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Rosa listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.